Lv4
450 积分 2025-10-17 加入
Current and Cutting Edge Methods of Portfolio Decision Analysis in Pharmaceutical R&D
2个月前
已完结
A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration
2个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT‐18 in Chinese Patients With Systemic Lupus Erythematosus
2个月前
已完结
Engineering of an Ultralong-Acting and Nonaggregating Dual Amylin and Calcitonin Receptor Agonist with Durable Efficacy in Obesity and Diabetes
5个月前
已完结
Portfolio-Wide Optimization of Pharmaceutical R&D Activities Using Mathematical Programming
6个月前
已完结
Acute graft-versus-host disease
7个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
7个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
7个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
8个月前
已完结
皖公网安备34019202002308
